Tirzepatide has emerged as a groundbreaking therapy for type 2 diabetes, offering promising outcomes. However, the cost of this innovative drug and its supply have become key topics for patients and healthcare professionals. While tirzepatide has been cleared by regulatory agencies, its high-priced nature presents a significant obstacle to many. D